NAD+ and GLP-1 combo routines: what the science supports

What did @mariahhopkins_ actually say?

She said NAD+ injections created a "night and day" difference in energy and brain focus, and that she noticed this difference clearly enough to convince herself the protocol works, despite her reluctance. Her main hesitation is logistical: five injections a week feels "overwhelming" as a busy mom, and she is considering dropping to two or three times weekly instead.

To her credit, she did not claim NAD+ cures anything. She framed this entirely as a personal experience, not medical advice. She expressed surprise that it worked at all, which is a more honest starting point than most wellness TikTok. What she did not address, at all, is what mechanism she believes is responsible for these effects, or whether the frequency she was prescribed has any clinical basis.

Does the science back this up?

The energy and cognitive benefits she describes are plausible, but the research is genuinely mixed and mostly early-stage. NAD+ precursors have shown promise, but injectable NAD+ as a standalone therapeutic is not yet supported by large randomized controlled trials in healthy adults.

NAD+ is a coenzyme involved in mitochondrial energy metabolism and DNA repair. Declining NAD+ levels with age are well-documented. Studies using oral precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) have shown that supplementation can raise NAD+ levels in blood and tissue (Martens et al., 2018, Cell Metabolism; Yoshino et al., 2021, Science). Whether injectable NAD+ raises those levels more effectively than oral precursors, or translates to subjective energy improvements in otherwise healthy people, is a different and much less settled question. The subjective "brain fog" improvements she describes match anecdotal reports in the literature, but placebo-controlled data here is thin. A 2023 pilot study (Brakedal et al., Nature Communications) showed NAD+ augmentation was safe but results on cognitive endpoints were modest at best.

What did they get wrong (or right)?

She got the self-awareness right. Saying she "didn't want it to work" is refreshingly honest and at least acknowledges the possibility of confirmation bias, even if she does not explicitly name it. That matters.

What she got wrong, or at least incomplete, is the implication that missing injections on certain days causes the dips she notices. That causal logic is shaky. NAD+ has a short half-life in plasma, but the downstream effects on cellular metabolism do not simply turn off the next morning. The "off days" she notices could reflect the placebo effect in reverse, a known phenomenon sometimes called nocebo response, or they could reflect unrelated factors like sleep, stress, or diet. She is not running a controlled experiment on herself, and she does not say so. That gap between personal observation and mechanism matters when other people are watching and deciding whether to start an injectable protocol.

The five-days-a-week frequency is also worth questioning. No published clinical protocol for subcutaneous NAD+ in general wellness has established that specific frequency as optimal. If her prescriber set that schedule, there should be a clinical rationale, and she did not mention one.

What should you actually know?

If you are considering NAD+ injections, here is what the evidence actually supports versus what remains speculative. NAD+ levels do decline with age and that decline is associated with metabolic and neurological changes. Raising NAD+ levels via supplementation appears safe in short-term human studies. Whether subcutaneous injections outperform oral precursors for the outcomes she describes has not been established in controlled trials.

The injection frequency question she raises is legitimate and underexplored. She plans to try two to three days weekly, which may be reasonable from a tolerability standpoint, but no published evidence establishes what the minimum effective frequency is for subcutaneous NAD+ in a wellness context. Anyone considering this protocol should have that conversation with a licensed provider, not base it on what feels logistically manageable.

Finally, compounded NAD+ products vary in concentration and formulation. Quality and sterility standards differ across compounding pharmacies, and compounded products are not equivalent to any standardized pharmaceutical preparation. That is a real safety consideration that did not come up in this video.